INDRAMEDCO

Indraprastha Medical Corporation Share Price

₹415.85 +0.6 (0.14%)

21 Nov, 2024 14:40

SIP TrendupStart SIP in INDRAMEDCO

Start SIP

Performance

  • Low
  • ₹402
  • High
  • ₹420
  • 52 Week Low
  • ₹155
  • 52 Week High
  • ₹490
  • Open Price₹414
  • Previous Close₹415
  • Volume139,012

Investment Returns

  • Over 1 Month -1.84%
  • Over 3 Month + 18.88%
  • Over 6 Month + 58.3%
  • Over 1 Year + 98.35%
SIP Lightning

Smart Investing Starts Here Start SIP with Indraprastha Medical Corporation for Steady Growth!

Invest Now

Indraprastha Medical Corporation Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 25.8
  • PEG Ratio
  • 0.6
  • Market Cap Cr
  • 3,812
  • P/B Ratio
  • 8
  • Average True Range
  • 22.78
  • EPS
  • 16.12
  • Dividend Yield
  • 1.1
  • MACD Signal
  • 2.26
  • RSI
  • 46.03
  • MFI
  • 68.14

Indraprastha Medical Corporation Financials

Indraprastha Medical Corporation Technicals

EMA & SMA

Current Price
₹415.85
+ 0.6 (0.14%)
pointer
  • stock-down_img
  • Bullish Moving Average 5
  • stock-up_img
  • Bearish Moving Average 11
  • 20 Day
  • ₹427.35
  • 50 Day
  • ₹416.43
  • 100 Day
  • ₹379.08
  • 200 Day
  • ₹318.98

Resistance and Support

416.93 Pivot Speed
  • R3 435.82
  • R2 430.08
  • R1 422.67
  • S1 409.52
  • S2 403.78
  • S3 396.37

What's your outlook on Indraprastha Medical Corporation?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Indraprastha Medical Corporation Ltd. operates the prestigious Indraprastha Apollo Hospitals in New Delhi, providing world-class healthcare services. It offers a wide range of medical specialties, advanced diagnostics, and state-of-the-art facilities for patients from India and abroad.

Indraprastha Med. (Nse) Corp. has an operating revenue of Rs. 1,318.87 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 13% is healthy, ROE of 25% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 40% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -10% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 92 which is a GREAT score indicating consistency in earnings, a RS Rating of 87 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 30 indicates it belongs to a strong industry group of Medical-Hospitals and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has great fundamentals and technical strength to stay in momentum.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Indraprastha Medical Corporation Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-30 Quarterly Results
2024-08-05 Quarterly Results
2024-05-17 Audited Results & Final Dividend
2024-02-06 Quarterly Results
2023-11-03 Quarterly Results

Indraprastha Medical Corporation F&O

Indraprastha Medical Corporation Shareholding Pattern

51%
2.66%
2.64%
0%
30.11%
13.59%

About Indraprastha Medical Corporation

  • NSE Symbol
  • INDRAMEDCO
  • BSE Symbol
  • 532150
  • Managing Director
  • Mr. Pattabhiraman Shivakumar
  • ISIN
  • INE681B01017

Similar Stocks to Indraprastha Medical Corporation

Indraprastha Medical Corporation FAQs

Indraprastha Medical Corporation share price is ₹415 As on 21 November, 2024 | 14:26

The Market Cap of Indraprastha Medical Corporation is ₹3812.2 Cr As on 21 November, 2024 | 14:26

The P/E ratio of Indraprastha Medical Corporation is 25.8 As on 21 November, 2024 | 14:26

The PB ratio of Indraprastha Medical Corporation is 8 As on 21 November, 2024 | 14:26

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23